Literature DB >> 21406654

An initial experiment with personalized antiplatelet therapy: the GRAVITAS trial.

Paul A Gurbel, Udaya S Tantry.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21406654     DOI: 10.1001/jama.2011.332

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

Review 1.  Anti-platelet therapy: ADP receptor antagonists.

Authors:  Yanushi Dullewe Wijeyeratne; Stan Heptinstall
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

Review 2.  Personalized antiplatelet therapy: state of the art.

Authors:  Paul A Gurbel; Young-Hoon Jeong; Udaya S Tantry
Journal:  JRSM Cardiovasc Dis       Date:  2012-09-24

3.  Platelet aggregation and risk of stent thrombosis or bleeding in interventionally treated diabetic patients with acute coronary syndrome.

Authors:  K Kukula; M Klopotowski; P K Kunicki; J Jamiolkowski; A Debski; P Bekta; M Polanska-Skrzypczyk; Z Chmielak; A Witkowski
Journal:  BMC Cardiovasc Disord       Date:  2016-12-08       Impact factor: 2.298

Review 4.  A Review of Danshen Combined with Clopidogrel in the Treatment of Coronary Heart Disease.

Authors:  Zhaojian Zhang; Yu Wang; Wangxiao Tan; Siwei Wang; Jinghua Liu; Xiao Liu; Xiaoying Wang; Xiumei Gao
Journal:  Evid Based Complement Alternat Med       Date:  2019-02-19       Impact factor: 2.629

5.  Towards personalized medicine based on platelet function testing for stent thrombosis patients.

Authors:  Thea Cornelia Godschalk; Christian Marcus Hackeng; Jurriën Maria Ten Berg
Journal:  Thrombosis       Date:  2012-12-25

6.  Factors related to on-treatment platelet aggregation assessed by multiple electrode aggregometry in percutaneous coronary intervention patients on clopidogrel and aspirin.

Authors:  Krzysztof Kukula; Mariusz Klopotowski; Joanna Was; Aleksandra Wrobel; Jacek Jamiolkowski; Artur Debski; Pawel Bekta; Zbigniew Chmielak; Adam Witkowski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2017-09-25       Impact factor: 1.426

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.